Epigenetic Aging Prediction via CpG Marker Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a systematic approach to describe and model epigenetic changes associated with human aging, making it difficult to quantify and compare aging rates across individuals, and link these changes to clinical or environmental variables.
Innovation Solution
A predictive model using genome-wide methylomic profiling to measure the rate of epigenetic aging based on methylation status at specific CpG markers, allowing for the identification of aging rates and tissue types through comparisons with reference populations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If genome-wide methylomic profiling is performed to measure epigenetic aging rates, then measurement precision of aging rates is improved, but device complexity and cost of the system increases
Solution Approach 1:
The genome-wide methylomic profiling is segmented into specific CpG marker measurements. Instead of analyzing the entire methylome, the invention focuses on a curated set of age-associated CpG markers that have been identified through preliminary analysis. This segmentation reduces the complexity of the measurement system while maintaining sufficient precision for aging rate assessment.
Solution Approach 2:
The invention extracts and isolates specific age-associated CpG markers from the entire methylomic profile. By identifying and measuring only the markers that show significant association with age, the system eliminates unnecessary measurements and simplifies the overall approach while preserving the ability to accurately measure epigenetic aging rates.
2Reliability
If systematic modeling of epigenetic changes is implemented, then reliability of aging rate prediction is improved, but difficulty of detecting and measuring increases
Solution Approach 1:
The invention performs preliminary identification and characterization of age-associated CpG markers before implementing the systematic modeling. Through preliminary analysis of methylation data across age groups, the invention identifies markers that show consistent age-related changes. This preliminary action simplifies subsequent measurement and modeling by focusing only on the most relevant markers.
Solution Approach 2:
The invention transforms the complex epigenetic data into a simplified parameter system based on methylation beta values at specific CpG markers. By changing the representation from raw methylomic profiles to processed methylation ratios at selected markers, the system makes detection and measurement of epigenetic aging more straightforward while maintaining prediction reliability.
3Adaptability or versatility
If tissue-specific aging patterns are identified through methylomic profiling, then adaptability of the model to different tissues is improved, but device complexity increases
Solution Approach 1:
The invention applies local quality by identifying and measuring different sets of CpG markers specific to each tissue type. Instead of using a universal marker set for all tissues, the system selects tissue-specific markers that show characteristic aging patterns in that particular tissue. This approach enables accurate tissue-specific aging detection while managing system complexity through targeted rather than comprehensive analysis.
Data Source
AI summary
The invention provides for methods for predicting age of a subject based on the epigenome of the subject.